AI for Pharma Growth: The Economics of Clinical Trials and the Relationship to AI
Clinical trials are a massive industry with brutal economics, long timelines, and failure rates that would be unacceptable in almost any other sector. In this episode, Dr. Andree Bates is joined by Dr. Joseph Geraci of NetraMark to break down why trials fail so often,...
Our Founding Story
Our Founding Story: How Uneven Treatment Patterns & Disease Definitions Inspired NetraMark’s Founding Authored & Edited By: Anna Falzon, Dr. Joseph Geraci, PhD Dr. Joseph Geraci, PhDFounder, CSO, & Chief Technology Officer at...
The MidDayBell: How NetraMark’s Explainable AI Could Transform Clinical Trials
George Achilleos, CEO of NetraMark, and Dr. Luca Pani, Chief Innovation & Regulatory Officer, discuss NetraMark’s explainable AI, model-derived subpopulations, a collaboration with NIMH, onboarding with Worldwide Clinical Trials, and an upcoming FDA Critical Path...
